MedTrace Logo

Integrated Prevention of HIV Risk and Intimate Partner Violence Among Adolescents in South Africa

NCT03179982 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-06-24

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to test the feasibility and acceptability of Safe South Africa, an integrated intervention for preventing HIV and Intimate Partner Violence perpetration for male adolescents 15-17 years of age.

Conditions

  • Sexual Behavior
  • Intimate Partner Violence

Interventions

BEHAVIORAL

Safe South Africa

Core components of the Safe South Africa intervention include the following: * Theory driven, best-evidence intervention approaches to adolescent HIV prevention * Linkages between HIV and IPV * Victim Empathy * Healthy Norms Regarding Masculinity * Bystander Intervention Skills

Sponsors & Collaborators

  • Medical Research Council, South Africa

    collaborator OTHER

  • Rhode Island Hospital

    collaborator OTHER

  • Brown University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
17 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2019-10-23
Completion
2021-05-31

Countries

  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03179982 on ClinicalTrials.gov